Effects of Developmental Care on Neurodevelopment of Preterm Infants.

Objectives The aim of this study protocol is to systematically review the literature to examine the effects of developmental care on preterm infants’ neurodevelopment in the neonatal intensive care unit (NICU). Materials & Methods Studies will be retrieved through searching the following databases: Web of Science, PubMed, EMBASE (Ovid), Cochrane Central Register of Controlled Trials (CENTRAL), CINAHL (EBSCO), and Scopus. Randomized controlled trials will be included with randomization at either individual or cluster level. The primary outcome will be to evaluate the effect of developmental care on the mental and motor development of NICU neonates. The secondary outcome will be neonatal weight gain and length of stay during NICU hospitalization. The assessment tool for the development should be the Bayley Scales of Infant and Toddler Development, in any of the first, second and third editions. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) will be employed to identify relevant articles and report the screening process. The agreement between two experts in developmental neonatology will be reached in selecting all studies. Afterward, data will be extracted and compared by two reviewers. Any discrepancies in the extracted data will be discussed to reach a consensus. The extracted data will be imported to Review Manager 5.3 by one reviewer. Finally, the risk of bias for all selected studies will be independently evaluated by two reviewers using the Cochrane Collaboration’s tool. A meta-analysis will be performed to assess the possible quantitative impact of developmental interventions on the desired primary and secondary objectives. A random effect will be used if the I-square statistics is equal or more than 75%; otherwise, a fixed effect will be applied. Publication bias will be assessed using Egger’s test and illustration with the funnel plot. The Standardized Mean Difference (SMD) with 95% confidence interval will be estimated through Metan command in STATA 14. The method provided in the Cochrane handbook will be used in this statistical analysis. The significance level will be 0.05.


Introduction
The birth rate of preterm infants has increased worldwide over the last few decades with technological advances. About 15 million preterm infants are born every year in the world; in other words, one in 10 infants is born prematurely (1). Moreover, the use of treatments such as antenatal steroid therapy, surfactant, positive pressure ventilation, and neonatal intensive care has increased the survival rate of preterm infants.
Prematurity and its complications are the main cause of death during infancy and also the second cause of death among children under five years of age (2), with nearly one million deaths in 2015.
Prematurity is also the leading cause of long-term developmental disabilities (3). Prematurity can cause a range of long-term and possibly lifelong complications in the metabolic, respiratory and nervous systems of individuals, as well as in their physical health. Complications related to prematurity are responsible for a part of the burden of chronic diseases in adults (4). Thus, focus on care for preterm infants hospitalized in neonatal intensive care units (NICU) has shifted from increased survival rates to reduced complications and improved quality of life (5)(6)(7). In the third trimester of pregnancy, important structures like the thalamus, the cortex, and the cerebellum are produced and the neuronal synaptic network is maximally developed. Therefore, from 24 to 40 weeks of gestation, the brain experiences a critical period of growth (8,9). Studies have shown that exogenous and endogenous experiences of preterm infants in NICU can lead to developmental disorders (10,11). In fact, NICU has harmful sensory effects on the immature brain of preterm infants and impairs their future development. Most infants admitted to NICU experience consequences such as separation from parents, recurrent aggressive and painful procedures, and excessive sensory stimulation, which are in contrast to expectations of the nervous system and lead to considerable changes in this system (12 to provide psychological support for parents and practical guidance on caring for their infants (16).
The effectiveness of developmental care in preterm infants has been studied in several systematic reviews (16)(17)(18)(19)(20)(21)(22)(23). In the studies by Symington and Pinelli (19,20) and Lavallée (21, 22), the effectiveness of five developmental care interventions in NICU was addressed. In other systematic reviews, post-NICU discharge interventions were studied. Nevertheless, developmental outcomes resulting from these interventions were not measured by a single instrument with high sensitivity and specificity (19,20,22). This has gained growing interest as

Materials & Method
To perform this review protocol, the Preferred Reporting Items for Systematic Reviews and Meta- Observational studies such as quasi-experimental (no randomization or no comparative group) and Cohort studies in addition to descriptive and casecontrol studies will be excluded. The research design provides the highest level of evidence and thus only randomized controlled trials will be included in the review protocol. There will be no time and language restrictions in the search strategy; however, published studies with English Iran J Child Neurol. Spring 2020 Vol. 14 No. 2 abstracts will be only included.
Participants: Studies on preterm infants (≤37 weeks of gestation) will be included in the review.
However, infants with intra-ventricular hemorrhage greater than grade II, brain malformation or any other health condition influencing their development will be excluded. Comparator: A non-exposed control group or a group exposed to different interventions will be included in the systematic review. Moreover, for identification of trials which are presently ongoing, the website clinicaltrials.gov will be re-checked. In order to recognize other possible relevant studies, references of included studies and previous related review articles will be screened. Text words and medical subject headings (MeSH/thesaurus terms) will be used to search databases.

Search strategy: Our initial search syntax for
PubMed is demonstrated in Table 1.

Screening of studies:
Duplicates of studies will be first investigated by two separate reviewers and then compared to affirm proper deletion of studies. Titles and abstracts will be screened to select relevant studies. Full texts of potentially eligible articles meeting the inclusion criteria will be read by three reviewers for inclusion in the review. Any disagreement about selecting articles Iran J Child Neurol. Spring 2020 Vol. 14 No. 2 will be resolved through discussion and consensus.
Data extraction of included studies will be carried out by the authors using a form designed for the review. Any discrepancies in extracted data will be discussed to reach a consensus. In a report form, the number of included and excluded studies along with explanations for exclusion will be noted.
Data extraction: Data extraction of included studies will be carried out by the authors using a form designed for the review. Any discrepancies in extracted data will be discussed to reach a consensus. Extracted data will be imported to Review Manager 5.3 by one reviewer.
For each study, data will be collected on the following domains: author, date of publication, design of study, location and setting of study, date of intervention, sample size, gestational age, birth weight, co-morbidities, inclusion and exclusion criteria, frequency of intervention delivery, duration of intervention, co-interventions, outcomes, assessment tools of outcomes, results, method of allocation and randomization, blinding of participants and outcome assessors, exclusion of participants after randomization and proportion of losses to follow-up.

Assessment of risk of bias:
The risk of bias for all included studies will be independently evaluated by two reviewers using the Cochrane Collaboration's tool for assessing risk of bias in randomized trials (28). Any disagreement will be resolved by discussion. The risk of bias tool assesses the following criteria: random sequence generation

Data synthesis and statistical analysis: If
selected studies are satisfactorily homogeneous for developmental, weight gain and length of hospital stay outcomes, a meta-analysis will be performed. A random effect will be chosen if I-square -as the heterogeneity criteria -is equal to or greater than 75%; otherwise, a fixed effect will be applied. Publication bias will be assessed using Egger's test and illustration with the funnel plot.
If there are multi-arm intervention and control groups in a trial, sample size, mean and standard deviation will be calculated for obtaining a single intervention and control group. The method provided by the Cochrane handbook will be used in this statistical analysis (28,29).
The significance level will be 0.05. Subgroup analysis will be on type of intervention, gestational age, and birth weight.
Missing data: Missing data will be obtained by contacting corresponding authors of articles.

Conflict of interest
The authors declare that there is no conflict of interest.

Discussion
This study will be the first systematic review that assesses the effect of NICU developmental care on neurodevelopment in preterm infants. According to findings of this systematic review, by abstracting results and presenting conclusions, interventional decisions can be improved. Further, by examining strengths and weaknesses of studies using metaanalysis, effectiveness of interventions will be elaborated and also a relatively straightforward conclusion will be achieved about long-term outcomes of developmental care in NICU for promoting preterm infants' neurodevelopment during hospitalization.
In the case of small studies, which have relative heterogeneity and limited quality, deficiency in existing evidence becomes clearer and suggestions such as research design, methods, sample size, and issues of test power can be recommended for further research. The results of this systematic review, by briefing areas (if there is sufficient evidence in this area), improving health interventions and, lacking sufficient evidence will mostly require the need to focus on next research activities and allocate more resources.

In conclusion
The clinical application could be enhanced to improve results and specifically neurodevelopment in preterm infants, with this knowledge.

Acknowledgement
The authors would like to thank the University of Social Welfare and Rehabilitation Sciences for their financial support.

Author`s contribution
Soleimani F., Azari N., and Fatollahierad S. will have substantial contributions to the conception and design of the work; they will have substantial Iran J Child Neurol. Spring 2020 Vol. 14 No. 2 contributions to acquisition, analysis, interpretation of data, drafting the work and revising it critically for important intellectual content. They will also contribute to obtain the final approval of the version to be published. In addition, all aspects of the work have been agreed to be accountable to ensure that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Ghiasvand H. will has substantial contributions to the conception and design of the work, analysis, and interpretation of data and also to the final approval of the version to be published. Moreover, he will agreee to be accountable for all aspects of the work to ensure that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.